Ronak Patel, MD
Pain Medicine · Plainsboro, NJNPI 1114273893
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 232 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 65.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $1,335 and has fallen 57.9% since, to $562 in 2025.
Across 232 payments — averaging $27.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$539
- Collegium Pharmaceutical, Inc.$412
- Si-bone, Inc.$290
- Nevro Corp.$206
- Globus Medical$159
- plus $629 from 14 others
What the payments were for
- Food & beverage$6,400100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 133 | $4,186 |
| Abbott | 35 | $539 |
| Collegium Pharmaceutical, Inc. | 27 | $412 |
| Si-bone, Inc. | 5 | $290 |
| Nevro Corp. | 6 | $206 |
| Globus Medical(2 entities) | 2 | $159 |
| Pacira Pharmaceuticals Incorporated | 1 | $124 |
| Stryker | 2 | $119 |
| Johnson & Johnson | 4 | $97 |
| Insulet Corporation | 4 | $64 |
| Vertos Medical, Inc. | 1 | $41 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Fidia Pharma USA Inc. | 2 | $32 |
| Amgen | 2 | $28 |
| Vertex | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Bioventus LLC | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$355
- WaveWriter Alpha Prime 16$259
- iFuse Implant$127
- RELINE$127
- EXPAREL$124
- Proclaim Family of SCS IPGs$115
- Omnia$114
- VITOSS$105
How this compares
$6,421 in reported general payments places this provider in the 80th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $342 |
| Gabapentin | 28 | $252 |
| Oxycodone Hcl | 24 | $215 |
| Tramadol Hcl | 17 | $38 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Plainsboro
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
- Dipan PatelClifton$50K
- Matthew LesneskiMount Laurel$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.